The presence of a detectable inactive oxidized form of GSTP1-1 has been recently found in salivary samples of healthy human subjects
The BUD is determined by the pharmacy based on USP (United States Pharmacopeia) guidelines and their own stability testing
All four core TRIUMPH trials are now complete, with the final two TRIUMPH-2 and TRIUMPH-3 reporting July 23, 2026
I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers
At 55, 214.5 lbs, 7.8% body fat recorded April 17, 2026